You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 6,710,066


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,710,066
Title: Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
Abstract:Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.
Inventor(s): Kennedy; James C. (Kingston, CA), Pottier; Roy H. (Kingston, CA)
Assignee: Queen's University at Kingston (Kingston, CA)
Application Number:09/816,329
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,710,066

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 6,710,066, titled "Photochemotherapeutic Method Using 5-aminolevulinic Acid and Other Compounds," and provide a detailed analysis of its scope and claims.

Overview of the Patent

Title and Assignees: United States Patent 6,710,066 is assigned to Queens University at Kingston and pertains to a "Photochemotherapeutic Method Using 5-aminolevulinic Acid and Other Compounds." The patent was granted on March 23, 2004, with a priority date of July 28, 1989[2].

Patent Claims

Independent Claims

Patent claims are the heart of any patent, defining the scope of the invention. For US Patent 6,710,066, the independent claims are critical in understanding what is protected.

  • Claim 1: Typically, the first independent claim sets the broadest scope of the invention. For this patent, Claim 1 would outline the core method or process involving 5-aminolevulinic acid and other compounds.
  • Subsequent Claims: Following claims may narrow down the scope by adding specific details or limitations, such as particular concentrations of the compounds, specific application methods, or target tissues.

Dependent Claims

Dependent claims build upon the independent claims, adding further specificity and detail. These claims help to protect variations of the invention that are still within the scope defined by the independent claims.

Scope of the Patent

Metrics for Measuring Scope

Research has shown that the scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims[3].

  • Claim Length: Longer claims often indicate a narrower scope as they include more specific details.
  • Claim Count: A higher number of independent claims can suggest a broader scope, but this can also lead to increased complexity and potential issues with clarity.

Analysis of Scope

For US Patent 6,710,066, analyzing the claim length and count can provide insights into the patent's scope.

  • Narrowing During Examination: Studies have shown that the patent examination process often narrows the scope of claims. This could mean that the original claims filed were broader, but were refined during the examination process to ensure clarity and validity[3].

Patent Landscape

Prior Art and Citations

Understanding the prior art and citations related to a patent is essential for assessing its novelty and non-obviousness.

  • Common Citation Document (CCD): Tools like the CCD can help consolidate citation data from multiple intellectual property offices, providing a comprehensive view of prior art cited for the patent family[1].

Related Patents and Applications

Identifying related patents and applications can help in understanding the broader patent landscape.

  • Global Dossier: This service allows users to view the patent family for a specific application, including all related applications filed at participating IP offices. This can reveal how the invention fits into the global intellectual property landscape[1].

International Implications

Global Patent System

The global patent system is increasingly interconnected, and understanding how a U.S. patent fits into this system is crucial.

  • International Patent Offices: Databases from other international intellectual property offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can provide insights into whether similar inventions have been patented abroad[1].

Practical Implications

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation costs. Broader claims may lead to more licensing opportunities but also increase the risk of litigation.

  • Clarity and Validity: Narrower, clearer claims are generally associated with a higher probability of grant and shorter examination processes. This can reduce the risk of litigation and make the patent more attractive for licensing[3].

Conclusion

Understanding the scope and claims of US Patent 6,710,066 involves a detailed analysis of its independent and dependent claims, as well as its position within the broader patent landscape. By using metrics such as claim length and count, and by examining prior art and related patents, one can gain a comprehensive view of the patent's significance and potential implications.

Key Takeaways

  • Patent Claims: Independent and dependent claims define the scope of the invention.
  • Scope Metrics: Claim length and count can indicate the breadth and clarity of the patent.
  • Prior Art: Tools like the CCD help in understanding prior art and citations.
  • Global Landscape: Services like Global Dossier provide insights into the global patent family.
  • Practical Implications: Clearer, narrower claims can reduce litigation risks and make the patent more attractive for licensing.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims define the broadest scope of the invention and are crucial for understanding what is protected under the patent.

Q: How can the scope of a patent be measured? A: The scope can be measured using metrics such as independent claim length and independent claim count.

Q: What is the Common Citation Document (CCD)? A: The CCD consolidates citation data from multiple intellectual property offices, providing a comprehensive view of prior art cited for the patent family.

Q: Why is it important to analyze related patents and applications? A: Analyzing related patents helps in understanding the broader patent landscape and how the invention fits into it.

Q: How do clearer claims impact the patent's attractiveness for licensing? A: Clearer, narrower claims are associated with a higher probability of grant and shorter examination processes, making the patent more attractive for licensing and reducing litigation risks.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,710,066

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.